Light Drizzle, 60° F
193 stories in March, 2011
The improbable appears promising
A section of the AIDS virus' protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising, new research by Harvard-affiliated Dana-Farber Cancer Institute scientists indicates.
For the 20 percent of patients with so-called triple-negative breast cancer, the outcome is bleak. Now, however, researchers from Harvard Medical School (HMS) and Baylor College of Medicine have identified a critical molecular component to the disease, one that suggests potential therapies involving combinations of FDA-approved, readily available drugs.
An unprecedented admissions year
Almost 35,000 students applied to Harvard College for admission to the Class of 2015. Letters of admission and email notifications were sent to 2,158 students, 6.2 percent of the record pool of 34,950. More than 60 percent of the admitted students will receive need-based scholarships averaging more than $40,000.
Brain changes found in normal elders
Harvard-affiliated researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta — the primary constituent of the plaques found in the brains of Alzheimer's disease patients — also had changes in brain structure similar to those seen in Alzheimer's patients.
For Libya, ‘no compromise’ in sight
Libyans want freedom, but the road to democracy is paved with unanswered questions. With the country torn by internal warfare, former Libyan diplomat Ali Suleiman Aujali and other experts gathered at the Harvard Kennedy School to look for answers.
In a Harvard School of Public Health webcast, researchers used a recent federal report to start a conversation on vitamin D. How much is enough, and how much is too much?
RSS Feed
© 2012 The President and Fellows of Harvard College